Ionis provides update on development program evaluating PCSK9 antisense medicine for the treatment of hypercholesterolemia

ION449 (AZD8233) met primary endpoint in Phase 2b SOLANO study for patients with hypercholesterolemia ION449 will not advance into Phase 3 development based on pre-specified criteria CARLSBAD, Calif., Sept. 23, 2022 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that topline results from the Phase 2b SOLANO study in […]

Earnings growth of 1.5% over 5 years hasn’t been enough to translate into positive returns for Union Bankshares (NASDAQ:UNB) shareholders

In order to justify the effort of selecting individual stocks, it’s worth striving to beat the returns from a market index fund. But even the best stock picker will only win with some selections. At this point some shareholders may be questioning their investment in Union Bankshares, Inc. (NASDAQ:UNB), since […]

Calendar of events, awards and opportunities

Every week, we update this list with new meetings, awards, scholarships and events to help you advance your career. If you’d like us to feature something that you’re offering to the bioscience community, email us with the subject line “For calendar.” ASBMB members’ offerings take priority, and we do not promote […]